Efficacy and Safety of Ostenil® Plus in the Treatment of Coxarthrosis

CompletedOBSERVATIONAL

Enrollment

170

Participants

Timeline

Start Date

February 15, 2019

Primary Completion Date

May 14, 2025

Study Completion Date

May 14, 2025

Conditions

Coxarthrosis

Interventions

DEVICE

Ostenil® Plus

Ostenil® Plus is a CE-certified viscoelastic solution for injection into the Joint cavity, containing 2.0 % Sodium hyaluronate from fermentation

Trial Locations (7)

Orthopädie Praxis, Ramelsloh

OrthopädieZentrum Maschen, Seevetal

Orthopädische Praxis Rahlstedt, Hamburg

Orthopädische Gemeinschaftspraxis Eutin, Eutin

Gemeinschaftspraxis für Orthopädie und Unfallchirurgie, Bad Oldesloe

Orthopraxis Kiel, Gettorf

Zentrum für Medizin des Bewegungsapparates, Heide

All Listed Sponsors

lead

TRB Chemedica AG

INDUSTRY

NCT03809962 - Efficacy and Safety of Ostenil® Plus in the Treatment of Coxarthrosis | Biotech Hunter | Biotech Hunter